Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 270-064-4 | CAS number: 68409-80-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
No skin sensitisation study with fatty acids, C6-19-branched, calcium salts is available, thus the skin sensitisation potential will be addressed with existing data on the individual moieties calcium and neodecanoate.
Fatty acids, C6-19-branched, calcium salts is not expected to show signs of dermal sensitisation, since the two moieties calcium and neodecanoate have not shown any skin sensitisation potential in experimental testing.
Key value for chemical safety assessment
Skin sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
Calcium
Evaluation of the sensitization potential of a substance was usually carried out in animal models. Nowadays, there is much interest in reducing and ultimately replacing current animal tests. The human cell line activation test (h-CLAT) and the ARE-Nrf2 luciferase test method were recently adopted as alternative methods for skin sensitization. Both test systems are based on human cell lines, such as the human monocytic leukaemia cells THP-1 and the KeratinoSens™ cells which are cultured either in RMPI-1640 medium or DMEM (OECD guideline No. 422D and 422E). Both media are supplemented with calcium salts at concentrations ranging from 2.5 to 5.0 mM. These methods were validated and accepted under these conditions and demonstrate that in vitro cell culture systems are dependent on calcium containing media.
Calcium is known for its key role in many regulatory functions in the skin. Calcium is mostly found in the outermost layer, the epidermis, where it is involved in barrier function repair and skin homeostasis (Dendaet al.,2003). Within the epidermis, keratinocytes have a different need for calcium concentrations. Keratinocyte differentiation throughout the epidermis is in part mediated by a calcium gradient, increasing from the stratum basale until the outer stratum granulosum, where it reaches its maximum. “Calcium concentration in the stratum corneum (SC) is very low because the relatively dry SC, with its extracellular lipid content, is not able to dissolve the ions. After disruption of the permeability barrier, an influx of water into the SC occurs and the calcium ion gradient is lost. This depletion of calcium regulates lamellar body exocytosis (Lee et al., 1992; Menon et al., 1985; Menon et al., 1991). Disturbed regulation of calcium metabolism and increased transepidermal water loss (Lavrijsen et al., 1993) is observed in Darier’s and Hailey– Hailey diseases, which are both characterized by loss of adhesion between suprabasal epidermal cells” (Prokschet al.,2008). Beside the fact, that calcium is a very important regulator of protein synthesis in the epidermis, including regulation of transglutaminase 1 activity (Hitomi, 2005) and cell–cell adhesion, the calcium gradient described above is involved in keratinocyte differentiation and as such considered as a key regulator in the formation of the epidermal layers (Proksch et al., 2008).
The turnover rate of the keratinocytes slows down with increasing age which is associated with thinning of the epidermis, elastosis and a decreased barrier function. Since the differentiation of the keratinocytes is calcium dependent, calcium plays a crucial role in the aging epidermis. Therefore, many calcium containing cosmetic products, especially anti-ageing products, are on the market. For example one of the long-lasting synthetic semi-permanent dermal fillers is calcium hydroxylapatite suspended in an aqueous carboxymethylcelluose gel carrier or calcium pantothenicum cream for regeneration of damaged skin. Radiesse® is one of these subdermal fillers, whose principal component is synthetic calcium hydroxylapatite (CaHA). Depending on injection site up to 4 mL of this product is injected (Jacovella, 2008). “The semi-solid nature of the product is created by suspending CaHA microspheres of 25–45 micron diameter in a gel carrier that consists primarily of sterile water and glycerin. The gel structure is formed by the addition of a small amount of carboxymethylcellulose (USP). The gel is dissipated in vivo and replaced with soft tissue growth, while the CaHA remains at the site of injection (Bioform Medical Inc. 2007)” (Jacovella, 2008). According to Flaharty (2000) the biocompatibility of CaHA has been tested in preclinical studies, and it has been shown to be non-toxic and non-mutagenic (Flaharty 2000).
Calcium hydroxide, calcium phosphate as well as calcium stearate are known ingredients of many commercial available products. “Calcium stearate was reported to be in 23 preparations in 1976, with the largest single use occurring in eyebrow pencils; concentrations ranged from >25 % to 50 %. In 2001, calcium stearate was reportedly used in 107 cosmetic preparations (FDA, 2001), with the largest single use occurring in eye shadow at concentrations that range from 0.2 % to 10 % (CTFA, 2001)” (The Cosmetic Ingredient Review (CIR) Expert Panel, 2001). The CIR Expert Panel evaluated the scientific data and concluded that calcium stearate and other stearates were safe for use in cosmetics and personal care products. In 2001, as part of the scheduled re-evaluation of ingredients, the CIR Expert Panel considered available new data on the stearate compounds and reaffirmed the above conclusion. According to the Regulation No. 1223/2009 of the European Parliament and of the Council on Cosmetic Products the use of calcium stearate is allowed in colorants and preservatives (EC No. 1223/2009 Annex IV and V).
For reference list please refer to endpoint summary of the moieties.
Neodecanoate
Neodecanoic acid has been examined for skin sensitization potential in the guinea pig maximization procedure of Magnusson and Kligman. Groups of ten male and ten female guinea pigs were used for the test and a further five males and five females as controls. Induction was accomplished in two stages.
1) Intradermal injection: Two rows of three injections were made, one on each side of the midline in the shorn skin of the shoulder region. 2) Topical application: One week after the intradermal injections, the same area was clipped free from hair. A 4x4 cm patch of filter paper was soaked in a solution of the test material and placed over the injection sites and covered with an occlusive dressing. The dressing was left in place for 48 hours. The challenge procedure was carried out two weeks after topical induction. Challenge was accomplished by topical application of the test material to the flank of animals via an occluded patch. The challenge lasted 24 hours. Immediately after the challenge, and then again at 24 and 48 hours later, each animals was examined for signs of skin sensitization. At no point was there any evidence of skin sensitization produced by neodecanoic acid.
Fatty acids, C6-19-branched, calcium salts
Fatty acids, C6-19-branched, calcium salts is not expected to show signs of dermal sensitisation, since the two moieties calcium and neodecanoate have not shown any skin sensitisation potential in experimental testing. Thus, fatty acids, C6-19-branched, calcium salts is not to be classified according to regulation (EC) 1272/2008 as skin sensitising. Further testing is not required. For further information on the toxicity of the individual assessment entities, please refer to the relevant sections in the IUCLID and CSR.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Fatty acids, C6-19-branched, calcium salts is not expected to show signs of dermal sensitisation, since the two moieties calcium and neodecanoate have not shown any skin sensitisation potential in experimental testing. Thus, fatty acids, C6-19-branched, calcium salts is not to be classified according to regulation (EC) 1272/2008 as skin sensitising.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.